Entrada Therapeutics stockholders elect three Class I directors, ratify auditor

Entrada Therapeutics, Inc.

Elected Dipal Doshi (27,809,399 for, 429,248 withheld), Kush M. Parmar (24,883,797 for, 3,354,850 withheld), Mary Thistle (27,768,093 for, 470,554 withheld).
Ratified Ernst & Young LLP as independent auditor for FY2025: 30,176,125 for, 74,925 against, 8,476 abstain.
Broker non-votes on director election totaled 2,020,879 shares.
Annual meeting held virtually on June 11, 2025; 30,259,526 shares represented (quorum).

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.